Location History:
- Munich, DE (2007)
- München, DE (2007 - 2008)
- Jesenwang, DE (2009 - 2011)
Company Filing History:
Years Active: 2007-2011
Title: Anne Girod: Innovator in Adeno-Associated Virus Research
Introduction
Anne Girod is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the study of adeno-associated viruses (AAV). With a total of 5 patents to her name, her work has implications for various medical applications.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Structural protein of adeno-associated virus with modified antigenicity, its production and its use." This invention relates to a structural protein of AAV that includes modifications aimed at reducing its antigenicity. This innovation is crucial for enhancing the safety and efficacy of AAV in therapeutic applications.
Career Highlights
Anne Girod is currently associated with Medigene AG, a company known for its focus on immunotherapy and innovative treatments. Her work at Medigene AG has positioned her as a key player in the advancement of viral vector technologies.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including Michael Hallek and Martin Ried. These partnerships have fostered a collaborative environment that enhances research and development in her field.
Conclusion
Anne Girod's contributions to the field of biotechnology, particularly in the area of adeno-associated viruses, highlight her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving therapeutic strategies.